Events
Search Results
Affiliated Programs
7.16.25
Biotech CEO Summit 2025
Wilson Sonsini is proud to sponsor the Biotech CEO Summit in Napa, the premier conference designed exclusively for CEOs in the life science industry. The Summits focus on the participating CEOs discussing issues of importance to them as leaders of companies they want to position for growth and success. The Summits are discussion based meetings led by subject matter experts. All participants are invited to, and indeed encouraged to join the discussions by asking questions and sharing their personal insights. The Summits are run under Chatham House Rules to encourage open and frank conversation.
Affiliated Programs
5.05.25
SynBioBeta 2025: The Global Synthetic Biology Conference
Wilson Sonsini is proud to sponsor SynBioBeta 2025: The Global Synthetic Biology Conference, where biology becomes the blueprint and human innovation, the artisan. Attend this event for an unparalleled four-day summit delving into synthetic biology.
Affiliated Programs
2.06.25
PBSS Workshop: Intellectual Property Strategies and Best Practices
Wilson Sonsini is proud to partner with the Pharmaceutical & BioScience Society (PBSS) to present a workshop on intellectual property strategies and best practices on Thursday, February 6 at the Crowne Plaza Foster City.
Affiliated Programs
1.14.25
Next in TechBio | Computational Drug Discovery and Data-driven Innovation
Wilson Sonsini is pleased to sponsor the Integrated Biosciences Next in TechBio event. Join us for a special cocktail evening to explore computational drug discovery and the transformative power of data-driven innovations. Featuring Eli Lilly’s Chief AI Officer moderating a panel discussion with TechBio CEOs from Integrated Biosciences, BigHat Biosciences, Owkin, Atommap, and Qubit Pharmaceuticals. There is also a Fireside Chat moderated by Benchling's CEO and participation with Wilson Sonsini Bay Area firm partners.
Speaking Engagements
9.12.24
IP Protection - Nucleate Seattle Genesis Lecture Series
On Thursday, September 12th, at 4:00pm at the UW CoMotion - Fluke Hall, patents and innovations partner Maya Skubatch will be participating in Nucleate Seattle’s most recent installment in the Genesis Lecture Series, an engaging panel on Intellectual Property Protection for biotech companies. This panel will cover the necessary regulations to adequately protect your intellectual property before moving into the market.
WSGR Events
6.13.24
Wilson Sonsini’s 31st Annual Medical Device & Digital Health Conference
Wilson Sonsini Goodrich & Rosati’s 31st Annual Medical Device & Digital Health Conference will address topics of critical importance to medical device and digital health companies today, including key healthcare regulatory considerations, the relationship between intellectual property and valuation, a look back at 2023’s fundraising and deals, and how 2024 is shaping up along with partnering strategies in the current market.
Speaking Engagements
3.28.24
Antibody-Drug Conjugates from Discovery to Development: Chemistry, Engineering, Characterization, CMC, PK/Tox, Clinical design and Intellectual Property
Wilson Sonsini partners Julia Minitti and Maya Skubatch recently spoke at the Antibody-Drug Conjugates Workshop hosted by Pharmaceutical & BioScience Society International. The workshop brought together various professionals and scientists to discuss the chemistry and engineering of antibody-drug conjugates (ADCs), clinical trials, intellectual property and more. Pharmaceutical & BioScience Society, International (PBSS) is a non-profit professional organization of scientists and other professionals in the life science sector, working in diverse organizations such as the biotechnology and pharmaceutical industries, instrumentation and scientific product suppliers, academia, government laboratories and contract research organizations. Many thanks to PBSS President Shichang Miao and the organizers for a fantastic opportunity to present!
WSGR Events
6.15.23
Wilson Sonsini’s 30th Annual Medical Device Digital Health Conference
Wilson Sonsini’s 30th Annual Medical Device Digital Health Conference will address topics of critical importance to medical device and digital health companies today, including key healthcare regulatory considerations, the relationship between intellectual property and valuation, a look back at 2022’s fundraising and deals, and how 2023 is shaping up along with partnering strategies in the current market.
WSGR Events
3.25.21
Innovator’s Edge Series: Regulatory Strategies in the Life Sciences
Wilson Sonsini is pleased to present the first of our 2021 Innovator’s Edge Series. Start-ups in the life sciences and biotech sectors, with an urgency to see their products come to market, continue to react to today’s ever-changing business and regulatory landscape. With an abundance of life sciences companies in the spotlight, regulatory strategic planning is more urgent than ever. The stakes are high as companies are faced with the task of navigating regulatory requirements and coordinating regulatory activity with business and patent strategies.